LeMaitre Vascular, Inc. (LMAT)
83.36
-0.30
(-0.36%)
USD |
NASDAQ |
Dec 11, 16:00
83.30
-0.06
(-0.07%)
Pre-Market: 20:00
LeMaitre Vascular Research and Development Expense (TTM): 14.22M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Baxter International, Inc. | 518.00M |
| Integra LifeSciences Holdings Corp. | 76.44M |
| ResMed, Inc. | 339.08M |
| Perspective Therapeutics, Inc. | 61.22M |
| Xtant Medical Holdings, Inc. | 2.165M |